Impella

Type: Product

Name: Impella

First reported May 18 2013 - Updated May 18 2013 - 1 reports

University of Miami Hospital sends team to Panama to save NCIS agent?s life

Avid runner Noel Zuniga had just finished his daily run, when he began experiencing chest pains.It was 6:30 p.m. on March 17, and Zuniga an NCIS agent in charge for the U. S. Embassy in Panama, had returned days earlier from a snorkeling trip. He had ... [Published Miami Herald - May 18 2013]

Entities: University of Miami Hospital, Panama, Impella, Heart Attack

First reported May 13 2013 - Updated May 13 2013 - 1 reports

FDA Food & Drug Administration

Trends and Advances in Hemodynamic Support

IAPBs, pVADs have similar outcomes in most cases, but cost is a major differentiatorDave FornellAbiomed introduced the Impella CP (Cardiac Power) pVAD in 2012, which delivers up to 4 lpm of flow.Since the 1970s, intra-aortic balloon pumps (IABPs) have ... [Published Diagnostic & Invasive Cardiology - May 13 2013]

Entities: Impella, FDA Food & Drug Administration, Abiomed Inc, Patient

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Abiomed Inc

Post Earnings Update: ABIOMED Has...

Two weeks ago on November 1st, 2012 ABIOMED (NASDAQ:ABMD) reported earnings and analysts, on average, expected earnings of $0.08 on sales of $37.3 million. The company actually reported EPS of $0.20 on sales of $37.4 million, beating EPS estimates by ... [Published Financial News Network online - May 08 2013]

Entities: Abiomed Inc, Impella, Cardiogenic Shock

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Abiomed continues rebound, expects to file Impella PMA this fiscal year

Abiomed CEO Michael Minogue says the company expects to file for pre-market approval from the FDA by the end of fiscal 2014, stressing that it's "business as usual" until then.Abiomed (NSDQ:ABMD) shares continued their rebound today from a plunge begun ... [Published MassDevice - May 06 2013]

Entities: Impella, Abiomed Inc, Fiscal Year, Michael Minogue

First reported May 04 2013 - Updated May 04 2013 - 1 reports

US Federal Business Opportunity: Department of Veterans Affairs: J--PM's for Impella and iPulse Systems at Edward Hines VA, IL.

Agency: Department of Veterans AffairsOffice: VA Great Lakes Healthcare System Location: Department of Veterans Affairs Great Lakes Healthcare SystemDate you need to respond by: 7-May-2013Solicitation Number: VA69D13Q1182 Naics code: 334510 Computer and ... [Published ITbriefing - May 04 2013]

Entities: Department of Veterans' Affairs, Impella, Federal, Danvers (Illinois, United States), System Location Co Ltd

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Abiomed reports double-digit increase in full-year revenue

Abiomed Inc. (Nasdaq:ABMD) said late Thursday that it’s total revenue for the full year that ended in March was $158.1 million, up 25 percent from the year before, and net income was $15 million, or 37 cents per share, 10 times the previous year.In the ... [Published Boston Business Journal - May 03 2013]

Entities: Abiomed Inc, Impella, Total Revenue

First reported May 03 2013 - Updated May 03 2013 - 3 reports

Abiomed Earnings Beat in 4Q - Analyst Blog

Abiomed Inc. 's ( ABMD ) fourth-quarter fiscal 2013 earnings per share (EPS) of 9 cents beat the Zacks Consensus Estimate of 7 cents by 28.6%. The Massachusetts.-based company registered a solid profit of $3.7 million, up 42.3% year over year.For fiscal ... [Published Nasdaq - May 03 2013]

Entities: Abiomed Inc, Impella, Investigational Device Exemption, transdermal

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Abiomed gains on surging FY2013 profits

Shares of Abiomed gain nearly 7% as investors react to Wall-Street-beating earnings and more than 900% bottom-line growth for the medical device company's fiscal 2013.Abiomed (NSDQ:ABMD) shares gained nearly 7% this morning after the medical device company ... [Published MassDevice - May 02 2013]

Entities: Abiomed Inc, Michael Minogue, Medical Devices, Impella

First reported May 01 2013 - Updated May 01 2013 - 4 reports

Abiomed: Costs of Impella heart pump come in well below national standards

Abiomed's Impella heart pumps improve patients' quality of life and costs well below the national standard for cost-effective therapies, according to the company.Heart support technologies maker Abiomed (NSDQ:ABMD) announced that its Impella heart pump ... [Published MassDevice - May 01 2013]

Entities: Impella, Abiomed Inc, Patient, Michael Minogue, Clinical trials

First reported Apr 30 2013 - Updated May 01 2013 - 1 reports

LRN, SPPI, ABMD, BDX Expected To Be Down Before Next Earnings Releases

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. K12 Inc ... [Published TradingCharts.com - Apr 30 2013]

Entities: Becton Dickinson and Company, Short Selling, K12 Inc, Spectrum Pharmaceuticals Inc, Abiomed Inc

First reported Apr 18 2013 - Updated Apr 18 2013 - 1 reports

Encouraging 4Q Prelims for Abiomed Zacks

Leading cardiac assist devices maker, Abiomed Inc. (ABMD), provided encouraging preliminary data for its fourth-quarter 2013 results. The company will report full results on May 2, 2013.Revenues climbed 17% year over year to $43.7 million. It increased ... [Published Yahoo! Finance - Apr 18 2013]

Entities: Impella, Abiomed Inc, Impella CP, Cyberonics Inc

First reported Apr 17 2013 - Updated Apr 17 2013 - 6 reports

Abiomed up on preliminary Q4 revenues

Abiomed Inc. (Nasdaq:ABMD) in Danvers, Mass. announced what it’s calling “preliminary” quarterly revenue that’s up double digits year-over-year, prompting investors to boost the medical device company’s stock up more than 5 percent Wednesday.Sales for ... [Published Boston Business Journal - Apr 17 2013]

Entities: Abiomed Inc, Impella CP, Impella

Quotes

"While we are not anticipating significant upside to quarterly results next week, we are comfortable with our estimates and view the recent pullback in the stock as an opportunity" Raymond James analyst Jayson Bedford wrote to clients

MARKET PULSE-Apple, Gilead, Aveo, GM, Visa, Facebook, Imperial Holdings [Published CNBC - May 02 2013]

...and record fiscal year in both number of patients supported and total revenue," chairman, president & CEO Michael Minogue said in prepared remarks. "Our company has transformed into a resilient commercial organization, that is profitable, debt-free and expanding the number of exclusive regulatory approvals, breakthrough innovative products and geographical reach."

Abiomed gains on surging FY2013 profits [Published MassDevice - May 02 2013]

"We are very excited about the continued expansion of compelling cost-effectiveness data for the Impella platform, which helps providers and payers navigate the evolving landscape of health care reform" Abiomed chairman, president & CEO Michael Minogue said in prepared remarks

Abiomed: Costs of Impella heart pump come in well below national standards [Published MassDevice - May 01 2013]

"This study indicates that new, minimally invasive technologies like Impella provide the opportunity for increased quality care and shared savings opportunities for all stakeholders. As the heart failure population proliferates, decision-makers will need to understand and balance the short-term costs of procedures versus the long-term costs for ongoing care" said David Gregory, MPA, FACHE, author of the study and Executive Vice President and Partner, Presscott Associates - A Division of ParenteBeard, LLC...

Abiomed Announces Publication of Protect II Cost Effectivene. . . [Published Equities.com - May 01 2013]

More Content

sort by: Date \| Relevance
University of Miami Hospital sends team to Pana... [Published Miami Herald - May 18 2013]
BSX and ABMD Highlight Increased Insider Buying... [Published Nasdaq - May 14 2013]
Trends and Advances in Hemodynamic Support [Published Diagnostic & Invasive Cardiology - May 13 2013]
Post Earnings Update: ABIOMED Has... [Published Financial News Network online - May 08 2013]
Abiomed continues rebound, expects to file Impe... [Published MassDevice - May 06 2013]
Report Published: "MediPoint: Cardiac Assist De... [Published Live-PR.com - May 05 2013]
US Federal Business Opportunity: Department of ... [Published ITbriefing - May 04 2013]
Abiomed reports double-digit increase in full-y... [Published Boston Business Journal - May 03 2013]
Abiomed Earnings Beat in 4Q - Analyst Blog [Published Nasdaq - May 03 2013]
Abiomed Earnings Beat in 4Q - Analyst Blog [Published Zacks.com - May 03 2013]
Abiomed Earnings Beat in 4Q Zacks [Published Yahoo! Finance - May 03 2013]
MARKET PULSE-Apple, Gilead, Aveo, GM, Visa, Fac... [Published CNBC - May 02 2013]
Abiomed gains on surging FY2013 profits [Published MassDevice - May 02 2013]
Abiomed Announces Fourth Quarter GAAP EPS of $0... [Published Interest!ALERT - May 02 2013]
Abiomed: Costs of Impella heart pump come in we... [Published MassDevice - May 01 2013]
Abiomed Announces Publication of Protect II Cos... [Published Equities.com - May 01 2013]
ABIOMED, INC. : Abiomed Announces Publication o... [Published 4 Traders - May 01 2013]
Abiomed Announces Publication of Protect II Cos... [Published Interest!ALERT - May 01 2013]
LRN, SPPI, ABMD, BDX Expected To Be Down Before... [Published TradingCharts.com - Apr 30 2013]
Abiomed gains on preliminary Q1 sales numbers [Published MassDevice - Apr 18 2013]
Startup Allecra Therapeutics Raises $19.5 Milli... [Published BioSpace - Apr 18 2013]
Encouraging 4Q Prelims for Abiomed Zacks [Published Yahoo! Finance - Apr 18 2013]
Startup Raises $19.5 Million Series A Financing [Published BioSpace - Apr 18 2013]
Forbion Capital Partners co-leads €15 Million S... [Published FierceBiotech - Apr 18 2013]
New Anti-Infectives Company, Allecra Therapeuti... [Published Yahoo! Finance - Apr 18 2013]
Abiomed up on preliminary Q4 revenues [Published Boston Business Journal - Apr 17 2013]
ABIOMED Crosses Above its 10-day MA (ABMD) [Published Scottrade - Apr 17 2013]
Abiomed Announces Preliminary Fourth Quarter Re... [Published Interest!ALERT - Apr 17 2013]
Abiomed 4Q sales up 17 percent, top Wall St. view [Published CNBC - Apr 17 2013]
Abiomed (ABMD) Prelim. Q4, FY12 Revs Top Views [Published Street Insider - Apr 17 2013]

Blogs

sort by: Date \| Relevance
Galena Presents Data, Sarepta Updates Study: He... [Published Wall St. Cheat Sheet - Dec 07 2012] Galena Biopharma ( NASDAQ:GALE ), through a Friday press release, said that it presented data from the completed SN-33 Trial and final results from the Phase 1/2 trials of NeuVax” (nelipepimut-S or E75), at the 35th Annual CTRC-AACR San Antonio Breast ...
Abiomed Concerns Deemed Overblown and 4 Stock A... [Published Wall St. Cheat Sheet - Nov 29 2012] Abiomed Inc. ( NASDAQ:ABMD ): Wunderlich said history shows that categories on the CMS list usually do not advance to the National Coverage Determination, or NCD, review stage. The firm believes concern of a possible NCD for Abiomed Inc.’s Impella ...

Press Releases

sort by: Date \| Relevance
Abiomed Announces First Impella RP Patient Enro... [Published GlobeNewswire: Acquisitions News - Apr 01 2013]
Abiomed Announces Revenue of $38.3 Million, Up ... [Published GlobeNewswire: Acquisitions News - Feb 06 2013]
Donaldson & Guin Investigates Abiomed, Inc. [Published GlobeNewswire: Acquisitions News - Dec 14 2012]
Investor Alert: Following Food and Drug Adminis... [Published EON Health & Medicine - Dec 07 2012]
Investor Alert: Following Food and Drug Adminis... [Published EON Business - Dec 07 2012]